Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells

A 69‐year‐old woman presented with splenic marginal zone lymphoma associated with acquired von Willebrand's disease (AVWD). Laboratory abnormalities included markedly decreased plasma levels of factor VIII coagulant (C) activity (VIII:C 28%), von Willebrand’s factor (VWF) antigen (Ag) (vWF:Ag ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 1997-03, Vol.96 (4), p.850-853
Hauptverfasser: TEFFERI, AYALEW, HANSON, CURTIS A., KURTIN, PAUL J., KATZMANN, JERRY A., DALTON, ROBERT J., NICHOLS, WILLIAM L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 853
container_issue 4
container_start_page 850
container_title British journal of haematology
container_volume 96
creator TEFFERI, AYALEW
HANSON, CURTIS A.
KURTIN, PAUL J.
KATZMANN, JERRY A.
DALTON, ROBERT J.
NICHOLS, WILLIAM L.
description A 69‐year‐old woman presented with splenic marginal zone lymphoma associated with acquired von Willebrand's disease (AVWD). Laboratory abnormalities included markedly decreased plasma levels of factor VIII coagulant (C) activity (VIII:C 28%), von Willebrand’s factor (VWF) antigen (Ag) (vWF:Ag 
doi_str_mv 10.1046/j.1365-2141.1997.d01-2088.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78907086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78907086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5209-c11bb00bab26988da0006019725f9a791719088ab83595b79e76668881259caa3</originalsourceid><addsrcrecordid>eNqVkEFv1DAUhC1EVZbCT0CyBIJTwnOyiW1xQG0FtKgSFxBHy05eildOnNpJ2fDrcbSrvffkw8w8z3yEvGWQM9jWH3c5K-sqK9iW5UxKnrfAsgKEyPfPyOakPScbAOBZyogX5GWMOwBWQsXOybkEvt2WsCH7y-ZhtgFb-ugH-ts6hyboof0QaWsj6oi0nZFOnmqDISkTxf0YMEab_L6jo9MTOpzovVsaPwY_oR3oraFmob0O93bQjv7zA1K39OMf32vaoHPxFTnrtIv4-vhekF9fv_y8vsnufny7vb68y5qqAJk1jBkDYLQpailEq9OkGpjkRdVJzSXjTKbl2oiykpXhEnld10IIVlSy0bq8IO8Pd1O1hxnjpHob1wZ6QD9HxUViAaJOxk8HYxN8jAE7NQabFiyKgVq5q51a2aqVrVq5q8RdrdzVPqXfHL-ZTY_tKXsEnfR3R13HRrsukWxsPNlSWSYLkWyfD7a_1uHylAbq6vuNrGT5H8P1n-4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78907086</pqid></control><display><type>article</type><title>Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library (Open Access Collection)</source><creator>TEFFERI, AYALEW ; HANSON, CURTIS A. ; KURTIN, PAUL J. ; KATZMANN, JERRY A. ; DALTON, ROBERT J. ; NICHOLS, WILLIAM L.</creator><creatorcontrib>TEFFERI, AYALEW ; HANSON, CURTIS A. ; KURTIN, PAUL J. ; KATZMANN, JERRY A. ; DALTON, ROBERT J. ; NICHOLS, WILLIAM L.</creatorcontrib><description>A 69‐year‐old woman presented with splenic marginal zone lymphoma associated with acquired von Willebrand's disease (AVWD). Laboratory abnormalities included markedly decreased plasma levels of factor VIII coagulant (C) activity (VIII:C 28%), von Willebrand’s factor (VWF) antigen (Ag) (vWF:Ag &lt; 6%), and VWF ristocetin cofactor (RCo) activity (VWF:RCo, &lt; 12%). VWF multimer analysis revealed a severe type II defect. Treatment with cryoprecipitate, high‐dose gamma globulin or desmopressin given intravenously was unsuccessful. Clinical bleeding and coagulation abnormalities showed transient improvement after replacement therapy with Humate‐P concentrate. The coagulation abnormalities improved partially after splenectomy and completely after subsequent chemotherapy. The neoplastic lymphocytes in the blood and spleen strongly expressed platelet glycoprotein Ib (CD42) and VWF but not other platelet‐associated antigens.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1046/j.1365-2141.1997.d01-2088.x</identifier><identifier>PMID: 9074430</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford, U.K. and Cambridge, USA: Blackwell Science Ltd</publisher><subject>acquired von Willebrand's disease ; Aged ; Antigens, Human Platelet - analysis ; Biological and medical sciences ; Female ; Flow Cytometry ; glycoprotein Ib ; Hematologic and hematopoietic diseases ; Humans ; Immunophenotyping ; Leukemia, Lymphocytic, Chronic, B-Cell - metabolism ; lymphoma ; Lymphoma, B-Cell - blood ; Lymphoma, B-Cell - complications ; Lymphoma, B-Cell - surgery ; Medical sciences ; Platelet diseases and coagulopathies ; Platelet Glycoprotein GPIb-IX Complex - metabolism ; Splenectomy ; Splenic Neoplasms - blood ; Splenic Neoplasms - complications ; Splenic Neoplasms - surgery ; von Willebrand Diseases - blood ; von Willebrand Diseases - etiology</subject><ispartof>British journal of haematology, 1997-03, Vol.96 (4), p.850-853</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5209-c11bb00bab26988da0006019725f9a791719088ab83595b79e76668881259caa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2141.1997.d01-2088.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2141.1997.d01-2088.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,1434,27929,27930,45579,45580,46414,46838</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2591928$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9074430$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TEFFERI, AYALEW</creatorcontrib><creatorcontrib>HANSON, CURTIS A.</creatorcontrib><creatorcontrib>KURTIN, PAUL J.</creatorcontrib><creatorcontrib>KATZMANN, JERRY A.</creatorcontrib><creatorcontrib>DALTON, ROBERT J.</creatorcontrib><creatorcontrib>NICHOLS, WILLIAM L.</creatorcontrib><title>Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>A 69‐year‐old woman presented with splenic marginal zone lymphoma associated with acquired von Willebrand's disease (AVWD). Laboratory abnormalities included markedly decreased plasma levels of factor VIII coagulant (C) activity (VIII:C 28%), von Willebrand’s factor (VWF) antigen (Ag) (vWF:Ag &lt; 6%), and VWF ristocetin cofactor (RCo) activity (VWF:RCo, &lt; 12%). VWF multimer analysis revealed a severe type II defect. Treatment with cryoprecipitate, high‐dose gamma globulin or desmopressin given intravenously was unsuccessful. Clinical bleeding and coagulation abnormalities showed transient improvement after replacement therapy with Humate‐P concentrate. The coagulation abnormalities improved partially after splenectomy and completely after subsequent chemotherapy. The neoplastic lymphocytes in the blood and spleen strongly expressed platelet glycoprotein Ib (CD42) and VWF but not other platelet‐associated antigens.</description><subject>acquired von Willebrand's disease</subject><subject>Aged</subject><subject>Antigens, Human Platelet - analysis</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>glycoprotein Ib</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Immunophenotyping</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - metabolism</subject><subject>lymphoma</subject><subject>Lymphoma, B-Cell - blood</subject><subject>Lymphoma, B-Cell - complications</subject><subject>Lymphoma, B-Cell - surgery</subject><subject>Medical sciences</subject><subject>Platelet diseases and coagulopathies</subject><subject>Platelet Glycoprotein GPIb-IX Complex - metabolism</subject><subject>Splenectomy</subject><subject>Splenic Neoplasms - blood</subject><subject>Splenic Neoplasms - complications</subject><subject>Splenic Neoplasms - surgery</subject><subject>von Willebrand Diseases - blood</subject><subject>von Willebrand Diseases - etiology</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkEFv1DAUhC1EVZbCT0CyBIJTwnOyiW1xQG0FtKgSFxBHy05eildOnNpJ2fDrcbSrvffkw8w8z3yEvGWQM9jWH3c5K-sqK9iW5UxKnrfAsgKEyPfPyOakPScbAOBZyogX5GWMOwBWQsXOybkEvt2WsCH7y-ZhtgFb-ugH-ts6hyboof0QaWsj6oi0nZFOnmqDISkTxf0YMEab_L6jo9MTOpzovVsaPwY_oR3oraFmob0O93bQjv7zA1K39OMf32vaoHPxFTnrtIv4-vhekF9fv_y8vsnufny7vb68y5qqAJk1jBkDYLQpailEq9OkGpjkRdVJzSXjTKbl2oiykpXhEnld10IIVlSy0bq8IO8Pd1O1hxnjpHob1wZ6QD9HxUViAaJOxk8HYxN8jAE7NQabFiyKgVq5q51a2aqVrVq5q8RdrdzVPqXfHL-ZTY_tKXsEnfR3R13HRrsukWxsPNlSWSYLkWyfD7a_1uHylAbq6vuNrGT5H8P1n-4</recordid><startdate>199703</startdate><enddate>199703</enddate><creator>TEFFERI, AYALEW</creator><creator>HANSON, CURTIS A.</creator><creator>KURTIN, PAUL J.</creator><creator>KATZMANN, JERRY A.</creator><creator>DALTON, ROBERT J.</creator><creator>NICHOLS, WILLIAM L.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199703</creationdate><title>Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells</title><author>TEFFERI, AYALEW ; HANSON, CURTIS A. ; KURTIN, PAUL J. ; KATZMANN, JERRY A. ; DALTON, ROBERT J. ; NICHOLS, WILLIAM L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5209-c11bb00bab26988da0006019725f9a791719088ab83595b79e76668881259caa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>acquired von Willebrand's disease</topic><topic>Aged</topic><topic>Antigens, Human Platelet - analysis</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>glycoprotein Ib</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Immunophenotyping</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - metabolism</topic><topic>lymphoma</topic><topic>Lymphoma, B-Cell - blood</topic><topic>Lymphoma, B-Cell - complications</topic><topic>Lymphoma, B-Cell - surgery</topic><topic>Medical sciences</topic><topic>Platelet diseases and coagulopathies</topic><topic>Platelet Glycoprotein GPIb-IX Complex - metabolism</topic><topic>Splenectomy</topic><topic>Splenic Neoplasms - blood</topic><topic>Splenic Neoplasms - complications</topic><topic>Splenic Neoplasms - surgery</topic><topic>von Willebrand Diseases - blood</topic><topic>von Willebrand Diseases - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TEFFERI, AYALEW</creatorcontrib><creatorcontrib>HANSON, CURTIS A.</creatorcontrib><creatorcontrib>KURTIN, PAUL J.</creatorcontrib><creatorcontrib>KATZMANN, JERRY A.</creatorcontrib><creatorcontrib>DALTON, ROBERT J.</creatorcontrib><creatorcontrib>NICHOLS, WILLIAM L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TEFFERI, AYALEW</au><au>HANSON, CURTIS A.</au><au>KURTIN, PAUL J.</au><au>KATZMANN, JERRY A.</au><au>DALTON, ROBERT J.</au><au>NICHOLS, WILLIAM L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>1997-03</date><risdate>1997</risdate><volume>96</volume><issue>4</issue><spage>850</spage><epage>853</epage><pages>850-853</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><abstract>A 69‐year‐old woman presented with splenic marginal zone lymphoma associated with acquired von Willebrand's disease (AVWD). Laboratory abnormalities included markedly decreased plasma levels of factor VIII coagulant (C) activity (VIII:C 28%), von Willebrand’s factor (VWF) antigen (Ag) (vWF:Ag &lt; 6%), and VWF ristocetin cofactor (RCo) activity (VWF:RCo, &lt; 12%). VWF multimer analysis revealed a severe type II defect. Treatment with cryoprecipitate, high‐dose gamma globulin or desmopressin given intravenously was unsuccessful. Clinical bleeding and coagulation abnormalities showed transient improvement after replacement therapy with Humate‐P concentrate. The coagulation abnormalities improved partially after splenectomy and completely after subsequent chemotherapy. The neoplastic lymphocytes in the blood and spleen strongly expressed platelet glycoprotein Ib (CD42) and VWF but not other platelet‐associated antigens.</abstract><cop>Oxford, U.K. and Cambridge, USA</cop><pub>Blackwell Science Ltd</pub><pmid>9074430</pmid><doi>10.1046/j.1365-2141.1997.d01-2088.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 1997-03, Vol.96 (4), p.850-853
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_78907086
source MEDLINE; Access via Wiley Online Library; EZB-FREE-00999 freely available EZB journals; Wiley Online Library (Open Access Collection)
subjects acquired von Willebrand's disease
Aged
Antigens, Human Platelet - analysis
Biological and medical sciences
Female
Flow Cytometry
glycoprotein Ib
Hematologic and hematopoietic diseases
Humans
Immunophenotyping
Leukemia, Lymphocytic, Chronic, B-Cell - metabolism
lymphoma
Lymphoma, B-Cell - blood
Lymphoma, B-Cell - complications
Lymphoma, B-Cell - surgery
Medical sciences
Platelet diseases and coagulopathies
Platelet Glycoprotein GPIb-IX Complex - metabolism
Splenectomy
Splenic Neoplasms - blood
Splenic Neoplasms - complications
Splenic Neoplasms - surgery
von Willebrand Diseases - blood
von Willebrand Diseases - etiology
title Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T19%3A47%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acquired%20von%20Willebrand's%20disease%20due%20to%20aberrant%20expression%20of%20platelet%20glycoprotein%20Ib%20by%20marginal%20zone%20lymphoma%20cells&rft.jtitle=British%20journal%20of%20haematology&rft.au=TEFFERI,%20AYALEW&rft.date=1997-03&rft.volume=96&rft.issue=4&rft.spage=850&rft.epage=853&rft.pages=850-853&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1046/j.1365-2141.1997.d01-2088.x&rft_dat=%3Cproquest_cross%3E78907086%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78907086&rft_id=info:pmid/9074430&rfr_iscdi=true